Faes Farma (LTS:0K9H) 3-Year Revenue Growth Rate : 3.60% (As of Jun. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Faes Farma 3-Year Revenue Growth Rate?

Faes Farma's Revenue per Share for the three months ended in Jun. 2023 was €0.34.

During the past 12 months, Faes Farma's average Revenue per Share Growth Rate was 1.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 3.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Faes Farma was 21.00% per year. The lowest was -8.40% per year. And the median was 4.05% per year.

Competitive Comparison of Faes Farma's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Faes Farma's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Faes Farma's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Faes Farma's 3-Year Revenue Growth Rate falls into.

Faes Farma 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Faes Farma (LTS:0K9H) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Faes Farma 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Faes Farma's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Faes Farma (LTS:0K9H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (LTS:0K9H) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

FAE:Spain FFEA:Germany

Address

Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940

Website

http://www.faes.es

Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma (LTS:0K9H) Headlines

No Headlines